» Articles » PMID: 30236476

A Contrast in Pathogenic Responses Between C57BL/6J and BALB/cJ Mice Using a Model of Retinal Injury

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 2018 Sep 22
PMID 30236476
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Ischemia is associated with the pathogenesis of retinal disease, including diabetic retinopathy and glaucoma. As a result, the retinal ischemia/reperfusion injury model has been used to study neurovascular changes. Historically, murine models of retinal disease are established in C57BL/6J (B6) mice, which have been described as type 1-dominant responders. In bacterial keratitis models, B6 mice are susceptible, whereas BALB/cJ (BALB/c; type 2-dominant) mice exhibit a resistant phenotype. As such, we questioned whether the type 1/type 2 paradigm could be extrapolated to events associated with retinal pathogenesis. The current study compares the retinal response of B6 with BALB/c mice to investigate strain-specific differences. Retinas were collected at 2 and 10 days after ischemia/reperfusion injury to examine differences in neurovascular degeneration, leukostasis, oxidative stress, glial activation, and select inflammatory mediators. Although both strains showed signs of retinal injury, significantly more damage was observed in B6 mice. Retinal thickness was reduced and vascular damage was more severe in B6 mice. Exacerbated response to injury in B6 versus BALB/c retinas was further supported by increased leukostasis, inflammatory mediators, reactive oxygen species, and lipid peroxidation. In addition, more terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling-positive cells and increased glial activation were detected in B6 mice. These data indicate that B6 and BALB/c retinas differentially respond to injury, which has broader implications regarding the development and study of retinal diseases.

Citing Articles

Immunological Landscape of Retinal Ischemia-Reperfusion Injury: Insights into Resident and Peripheral Immune Cell Responses.

He S, Liu C, Ren C, Zhao H, Zhang X Aging Dis. 2024; .

PMID: 38502592 PMC: 11745425. DOI: 10.14336/AD.2024.0129.


A Method for Real-Time Assessment of Mitochondrial Respiration Using Murine Corneal Biopsy.

Liang W, Huang L, Yuan T, Cheng R, Takahashi Y, Moiseyev G Invest Ophthalmol Vis Sci. 2023; 64(11):33.

PMID: 37642632 PMC: 10476441. DOI: 10.1167/iovs.64.11.33.


Adjunctive Thymosin Beta-4 Treatment Influences PMN Effector Cell Function during -Induced Corneal Infection.

Wang Y, Carion T, Ebrahim A, Sosne G, Berger E Cells. 2021; 10(12).

PMID: 34944086 PMC: 8700181. DOI: 10.3390/cells10123579.


Evaluation of Susceptibility and Innate Immune Response in C57BL/6 and BALB/c Mice During Candida albicans Endophthalmitis.

Rottmann B, Singh P, Singh S, Revankar S, Chandrasekar P, Kumar A Invest Ophthalmol Vis Sci. 2020; 61(11):31.

PMID: 32940660 PMC: 7500134. DOI: 10.1167/iovs.61.11.31.


Nanoceria distribution and effects are mouse-strain dependent.

Yokel R, Tseng M, Butterfield D, Hancock M, Grulke E, Unrine J Nanotoxicology. 2020; 14(6):827-846.

PMID: 32552239 PMC: 8496957. DOI: 10.1080/17435390.2020.1770887.


References
1.
Muller A, Schott-Ohly P, Dohle C, Gleichmann H . Differential regulation of Th1-type and Th2-type cytokine profiles in pancreatic islets of C57BL/6 and BALB/c mice by multiple low doses of streptozotocin. Immunobiology. 2002; 205(1):35-50. DOI: 10.1078/0171-2985-00109. View

2.
De Vooght V, Vanoirbeek J, Luyts K, Haenen S, Nemery B, Hoet P . Choice of mouse strain influences the outcome in a mouse model of chemical-induced asthma. PLoS One. 2010; 5(9):e12581. PMC: 2935354. DOI: 10.1371/journal.pone.0012581. View

3.
Schulte S, Sukhova G, Libby P . Genetically programmed biases in Th1 and Th2 immune responses modulate atherogenesis. Am J Pathol. 2008; 172(6):1500-8. PMC: 2408411. DOI: 10.2353/ajpath.2008.070776. View

4.
Ramirez A, de Hoz R, Salobrar-Garcia E, Salazar J, Rojas B, Ajoy D . The Role of Microglia in Retinal Neurodegeneration: Alzheimer's Disease, Parkinson, and Glaucoma. Front Aging Neurosci. 2017; 9:214. PMC: 5498525. DOI: 10.3389/fnagi.2017.00214. View

5.
Abcouwer S, Lin C, Wolpert E, Shanmugam S, Schaefer E, Freeman W . Effects of ischemic preconditioning and bevacizumab on apoptosis and vascular permeability following retinal ischemia-reperfusion injury. Invest Ophthalmol Vis Sci. 2010; 51(11):5920-33. DOI: 10.1167/iovs.10-5264. View